Share
Journal Information
Editorial
Unconventional and alternative therapies in the era of major therapeutic advances in rheumatology
Guillermo Hernández Ríos, Sergio Durán Barragán, César Ramos-Remus
Reumatol Clin. 2006;2:161-3
Full text access
Open Article
Original article
Identification of the best sites for the histopathological study of tarsitis in patients with spondyloarthropathies
Rebeca Ramírez González, María Virgilia Soto Abraham, Antonio Ugalde Viteli, César Pacheco Tena, Rubén Burgos-Vargas
Reumatol Clin. 2006;2:164-7
Full text access
Open Article
Relationship between COMT gene genotypes and the severity of fibromyalgia
Ferran Josep García-Fructuoso, José Ignacio Lao-Villadóniga, Katrin Beyer, Cristina Santos
Reumatol Clin. 2006;2:168-72
Full text access
Open Article
Systematic review: can botulinum toxin be recommended as treatment for pain in myofascial syndrome?
Claudia Alejandra Pereda, Jacqueline Usón Jaeger, Loreto Carmona
Reumatol Clin. 2006;2:173-82
Full text access
Open Article
Complementary and alternative medicine in patients attending a rheumatology department for the first time. Analysis of 800 cases
Everardo Álvarez-Hernández, Julio César Casasola-Vargas, Leticia Lino-Pérez, Rubén Burgos-Vargas, Janitzia Vázquez-Mellado
Reumatol Clin. 2006;2:183-9
Full text access
Open Article
Case report
Necrotizing fasciitis as the first manifestation of tuberculosis in an immunocompromised patient
Fernando Salgado Ordóñez, Rafael Fúnez Liébana, Francisco Pérez Nadal, Elsa García González
Reumatol Clin. 2006;2:212-6
Full text access
Open Article
Special content about COVID-19
- Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Publish in
Reumatología Clínica